Boxer Capital’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Boxer Capital’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-890,700	Closed	-$3.55M	–	95
2021 Q3	$3.55M	Hold	890,700	–	–	0.12%	78
2021 Q2	$3.81M	Hold	890,700	–	–	0.13%	84
2021 Q1	$3.78M	Hold	890,700	–	–	0.13%	76
2020 Q4	$3.46M	Hold	890,700	–	–	0.11%	72
2020 Q3	$3.59M	Hold	890,700	–	–	0.12%	70
2020 Q2	$3.79M	Hold	890,700	–	–	0.17%	61
2020 Q1	$3.74M	Buy	890,700 +115,700	+15%	+$731K	0.26%	52
2019 Q4	$3.05M	Hold	775,000	–	–	0.17%	49
2019 Q3	$6.82M	Buy	775,000 +200,000	+35%	+$1.89M	0.49%	38
2019 Q2	$5.32M	Buy	+575,000	New	+$4.33M	0.46%	32
2018 Q2	–	Sell	-267,500	Closed	-$7.97M	–	37
2018 Q1	$7.97M	Hold	267,500	–	–	0.85%	22
2017 Q4	$8.61M	Hold	267,500	–	–	1.57%	17
2017 Q3	$9.3M	Hold	267,500	–	–	2.12%	13
2017 Q2	$7.96M	Buy	267,500 +100,100	+60%	+$2.87M	1.89%	13
2017 Q1	$5M	Buy	+167,400	New	+$4.27M	1.09%	15

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kevin Tang $783 AUM 75.59% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Boxer Capital's LJPC Position: Q4 2021 in Review

Boxer Capital sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2021, closing a stake of 890,700 shares — an estimated $3.55M sold.

Boxer Capital first reported a position in LJPC in Q1 2017 and held it in 15 quarters. The position peaked at $9.3M in Q3 2017. 44 funds tracked by Wall St. Rank hold LJPC as of Q4 2021.

Boxer Capital reported no remaining La Jolla Pharmaceutical Company position as of Q4 2021 after selling out during the quarter.
Boxer Capital sold 890,700 La Jolla Pharmaceutical Company shares in Q4 2021, an estimated $3.55M.
Boxer Capital first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 15 quarters.
Boxer Capital's La Jolla Pharmaceutical Company position peaked at $9.3M in Q3 2017.
44 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2021.

Based on Boxer Capital's 13F filing for Q4 2021, filed 14 Feb 2022.